| Date |
Speakers(s) |
Program
Topic |
 |
| January
2010 |
Tom White, PhD
CSO & SVP
Celera Corporation |
Genomic and Proteomic Biomarkers that Predict Risk for Diseases and the Outcome of Drug Therapy |
| February
2010 |
Maria Walker
Senior Director, Venture Capital Practice
KPMG |
Everthing You Ever Wanted to Know About Venture Capital But Was Afraid to Ask |
| March
2010 |
Steve Rosenberg
Chief Scientific Officer
CardioDx |
Personalized Medicine: Yesterday, Today, and Tomorrow |
| April
2010 |
Jean Deleage, Ph.D.
Founding Partner & Managing Director
Alta Partners |
Biotechnology Investing from 1976 to the Present: Successes and Lessons Learned |
| May 2010 |
Philip D. Gregory, D. Phil.
Chief Scientific Officer and Vice President, Research
Sangamo BioSciences, Inc |
ZFP Therapeutics - Exploiting DNA as a Platform for Drug Development |
| June 2010 |
Hing Sham, Ph.D.
Senior Vice President, Chemical Sciences
Elan Pharmaceuticals |
Discovery of Two Generations of HIV Protease Inhibitors |
